Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review
Open Access
- 9 February 2021
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 14 (5), 509-520
- https://doi.org/10.1158/1940-6207.capr-20-0633
Abstract
Obesity represents one of the most significant public health challenges worldwide. Current clinical practice relies on body mass index (BMI) to define the obesity status of an individual, even though the index has long been recognized for its limitations as a measure of body fat. In normal BMI individuals, increased central adiposity has been associated with worse health outcomes, including increased risks of cardiovascular disease and metabolic disorders. The condition leading to these outcomes has been described as metabolic obesity in the normal weight (MONW). More recent evidence suggests that MONW is associated with increased risk of several obesity-related malignancies, including postmenopausal breast, endometrial, colorectal, and liver cancers. In MONW patients, the false reassurance of a normal range BMI can lead to lost opportunities for implementing preventive interventions that may benefit a substantial number of people. A growing body of literature has documented the increased risk profile of MONW individuals and demonstrated practical uses for body composition and biochemical analyses to identify this at-risk population. In this review, we survey the current literature on MONW and cancer, summarize pathophysiology and oncogenic mechanisms, highlight potential strategies for diagnosis and treatment, and suggest directions for future research.Keywords
Funding Information
- Breast Cancer Research Foundation (BCRF-19–034)
- Breast Cancer Research Foundation (BCRF-19–140)
- NCI (U54 CA210184)
This publication has 102 references indexed in Scilit:
- Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased AngiogenesisCancer Research, 2012
- Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profileNature Genetics, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Targeting the PI3K signaling pathway in cancerCurrent Opinion in Genetics & Development, 2010
- Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortalityEuropean Heart Journal, 2009
- Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US populationEuropean Heart Journal, 2008
- Effects of adiponectin on breast cancer cell growth and signalingBritish Journal of Cancer, 2008
- Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathwaysEndocrine-Related Cancer, 2006
- Estrogen Carcinogenesis in Breast CancerThe New England Journal of Medicine, 2006
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004